NeuroOne Medical Technologies (NMTC) vs SiNtx Technologies (SINT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
SiNtx Technologies (SINT) has outperformed NeuroOne Medical Technologies (NMTC) over the past year, losing 53.3% versus a loss of 82.7%. Over five years, NMTC leads with a -94.0% price change compared with -100.0% for SINT. SiNtx Technologies is the larger company by market cap ($14.1 million vs $9.9 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NMTC | SINT |
|---|---|---|
| Share price | $1.09 | $2.11 |
| Market cap | $9.94M | $14.06M |
| 1-day change | +1.12% | 0.00% |
| YTD return | -76.25% | -45.34% |
| 1-year return | -82.69% | -53.32% |
| 5-year return | -94.00% | -99.99% |
| EPS (TTM) | $-0.99 | $-4.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.42 | $4.64 |
| 52-week low | $0.962 | $1.40 |
| Distance from 52-week high | -82.99% | -54.53% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +565.69% | +338.39% |
| Average volume | 339.60K | 112.93K |
| Shares outstanding | 9.11M | 6.66M |
| Employees | 18 | 32 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SINT has outperformed NMTC by 29.4 percentage points over the past year.
About NeuroOne Medical Technologies
NMTC stock →NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders.
Health Care · Medical/Dental Instruments · 18 employees
About SiNtx Technologies
SINT stock →Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE).
Health Care · Medical/Dental Instruments · 32 employees
NMTC vs SINT FAQ
Which is bigger, NeuroOne Medical Technologies or SiNtx Technologies?
SiNtx Technologies (SINT) is larger, with a market capitalization of $14.06M compared with $9.94M for NeuroOne Medical Technologies (NMTC).
Which stock has performed better over the past year, NMTC or SINT?
SINT returned -53.32% over the past 12 months, compared with -82.69% for NMTC (price return, excluding dividends). Past performance does not predict future results.
Are NeuroOne Medical Technologies and SiNtx Technologies in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.